As the life sciences industry enters 2025, gen AI is set to be a driving force behind groundbreaking innovations. This panel discussion will explore key predictions for how gen AI investments are reshaping the future of life sciences, particularly in drug discovery, biomarker identification and personalized medicine. We’ll dive into the latest research investments, highlighting the surge in AI and data analytics spending and the potential these technologies hold for transforming drug discovery, clinical development and regulatory processes.
Join experts Lisa Arbogast, Industry Principal for Life Sciences at Snowflake; Harini Gopalakrishnan, Global Field CTO for Life Sciences at Snowflake in a forward-looking discussion to hear about:
- Strategies for staying competitive in this evolving landscape
- The steps necessary to harness the full potential of data and AI in 2025 and beyond